For example, it has been shown that in non-alcoholic fatty liver disease, changes in the levels of miR-150-5p and miR-200a-3p [141] can post-transcriptionally suppress CYP3A4 [138,140,141,142], whereas miR-34a, miR-30c-1-3p and miR-27b suppress CYP3A4, affecting RXRa, PXR and VDR [136,140]. This evidence concerns the gene CYP3A4 and metabolic dysfunction-associated steatotic liver disease.